Single-Fraction Radiotherapy for CD30⁺ Lymphoproliferative Disorders

Figure 1

(a) Patient with primary cutaneous CD30⁺ lymphoproliferative disorder (LPD) of the left lower extremity. The gross lesion is a raised nodule with central ulceration and surrounding erythema. (b) The same patient at follow-up visit 8 months after completion of a single fraction of radiation therapy (RT) to 800 cGy. There is no clinical evidence of residual cutaneous lymphoma. All what remains is fibrotic tissue, which continues to fade. There was no evidence of recurrence at the last follow-up 27 months after treatment.

(a)

(b)